GLP-1 agonists, widely used to treat type 2 diabetes and manage obesity, were associated with a lower risk of metastatic progression of certain obesity-related cancers, in particular lung, breast, colorectal and liver cancer, according to study results presented at a media briefing in advance of the upcoming American Society of Clinical Oncology Annual Meeting (ASCO 2026)
Sarker and Gohda, 2013), antiobesity and lipid lowering (Kazemipoor et al., 2015
If you're considering Tirzepatide for weight loss, schedule a consultation, our team is here to guide you every step of the way, ensuring that your treatment plan is both safe and effective
Change in waist circumference : The mean change in waist circumference was 18.4 cm with tirzepatide (95% CI, 19.6 to 17.2) and 13.0 cm with semaglutide (95% CI, 14.3 to 11.7)
Proporcione su correo electrnico para recibir una gua paso a paso sobre cmo importar de forma segura y legal medicamentos que no estn disponibles en su pas
Time to Results: Noticeable Appetite Reduction: GLP-1s (semaglutide, tirzepatide): 1-2 weeks Phentermine: 1-3 days Phentermine-topiramate: 1-2 weeks Naltrexone-bupropion: 4-8 weeks Orlistat: Doesnt reduce appetite Measurable Weight Loss: Tirzepatide: 5-8% by week 20, 15-22% by week 72 Semaglutide: 5-7% by week 20, 10-15% by week 68 Phentermine-topiramate: 5-6% by week 28 Others: 3-5% by week 24-28 GLP-1s produce steady, sustained weight loss over 16-20 months
